Introduction {#S0001}
============

The safest and most effective implant for ventral hernia repair has been debated repeatedly since the advent of prosthetic mesh in the 1940s. The existing literature report varying results for infection rates and hernia recurrence with meshes placed in a myriad of positions. In particular, there has been longstanding controversy regarding the use of polypropylene (PP) versus polyester (PET) mesh. A landmark study in 1998 compared comparing hernia outcomes between PP, PET, and ePTFE meshes demonstrated a significantly greater incidence of enterocutaneous fistula formation, mesh infections, and recurrences with multifilament PET mesh compared to other materials.[@CIT0001] This paper launched a debate regarding the efficacy of PET mesh that has spanned decades, resulting in a shift toward PP and ePTFE meshes.

Subsequent studies reported good outcomes with low morbidity following PET mesh hernia repair.[@CIT0001],[@CIT0002] Placing PET mesh in an extraperitoneal location was identified as essential in the prevention of enterocutaneous fistulas.[@CIT0003] In the prior study, PET had been placed within the peritoneal cavity, with nothing to protect the viscera from contact with the mesh. In the largest retrospective review of PET mesh hernia repairs with retrorectus or preperitoneal positioning, the overall recurrence rate was 1.5% and complication rate of 6.3%.[@CIT0003],[@CIT0004]

In the decades to follow, numerous mesh products have been developed, including coated and composite meshes that allow for intraperitoneal mesh placement while minimizing risk of erosion of mesh into viscera. Colon et al reported no difference in postoperative complications and recurrence rates at 12 months following laparoscopic ventral hernia repair between PET composite and ePTFE mesh materials.[@CIT0005] Advancements in engineering have also allowed for variations in mesh weight and pore size.[@CIT0006] Heavyweight (HW) meshes generally have smaller pore sizes, but greater tensile strength due to the material itself, which activates a profound tissue reaction and dense scarring.[@CIT0007] Smaller pore sizes may also limit bacterial clearance in the setting of infection. Alternatively, lighter weight products are reported to have greater tissue integration, more elasticity with retained tensile strength, and larger pore size meshes have greater likelihood to integrate in the setting of postoperative infections.[@CIT0007] The durability of lightweight (LW) mesh implanted in ventral hernia repairs has been debated repeatedly. However, multiple studies have found no difference in recurrence rate based on mesh weight with follow-up greater than 2 years.[@CIT0006],[@CIT0008]--[@CIT0010] While most of the studies evaluating outcomes between LW and HW mesh evaluated PP materials, a 2015 study reported poor outcomes with LW PET mesh. In this study of 36 patients with LW PET mesh placed in the retro-rectus position, 8 (22%) recurrent hernias were identified. On reoperation, the authors reported that 7 of the 8 recurrences were due to a mechanical failure or fracturing of the mesh itself.[@CIT0011] This study further fueled the debate regarding the efficacy of both LW mesh materials and PET.

The majority of studies comparing mesh materials are limited in patient numbers and often have inadequate follow-up to accurately determine long-term outcomes. In an effort to determine if mesh weight or material impacted hernia outcomes, we performed a systematic literature review and descriptive meta-analysis of ventral and incisional hernia repair studies specifically focused on estimating the risk of recurrence and infection in ventral hernia repair using PP and PET mesh.

Materials and methods {#S0002}
=====================

Search criteria {#S0002-S2001}
---------------

A comprehensive literature search was performed using the Ovid search platform. This platform encompassed 12 databases: Journals\@Ovid Full Text, EBM Reviews -- Cochrane Database of Systematic Reviews, EBM Reviews -- ACP Journal Club, EBM Reviews -- Database of Abstracts of Reviews of Effects, EBM Reviews -- Cochrane Central Register of Controlled Trials, EBM Reviews -- Cochrane Methodology Register, EBM Reviews -- Health -- Cochrane Central Register of Controlled Trials, EBM Reviews -- Cochrane Methodology Register, EBM Reviews -- Health Technology Assessment, EBM Reviews -- NHS Economic Evaluation Database, BIOSIS Previews, Embase, Inspec, and MEDLINE.

Databases were searched using the keywords "ventral AND hernia AND mesh AND recurrence AND (placement OR overlap OR position)" and "Ventral hernia mesh repair." The literature was searched for articles discussing polyethylene terephthalate (PET) or polypropylene (PP) mesh used in ventral, incisional, or parastomal hernia procedures. Both generic PET/PP mesh terms and specific product terms were included in the search. No date filter was applied to this search.

Inclusion and exclusion criteria {#S0002-S2002}
--------------------------------

Studies that met the above search criteria were considered for analysis. From these studies, those written in English or French, with a sample size of ≥25 patients, a mean follow-up ≥1 year, and an Oxford Classification of level 1, 2, or 3 were included in the final analysis. Studies that provided no clinical data or did not describe recurrence rate were excluded either for recurrence risk estimations. Additionally, studies that included Parietex™ and Parietene™ ProGrip™ self-gripping polyester (as the PLA grip provides fixation that can influence the recurrence results), studies that included Adhesix™ (that includes adherent properties) and studies with multiple meshes where it was not possible to clearly assign the results to the mesh were also excluded.

Data extraction {#S0002-S2003}
---------------

For comparative studies, each arm was assessed individually and inclusion/exclusion criteria were implemented for each arm. When prospective or retrospective papers reported different kinds of meshes, the subgroups were included only if the results were detailed enough to be able to assign the complications to different meshes with certainty and if each subgroup met inclusion criteria. When mesh weight was not described in the paper, but either the brand or the mesh was identified with certainty, mesh weight was obtained from the company website, brochures, or publications.

The extracted data included the following: First author, year of publication, mesh studied, mesh weight, material, manufacturer, surgical approach, number of patients, hernia type, Oxford classification, methodology, mesh positioning, fascial closure, number of hernias treated, mean follow-up, previous ventral repair, number of recurrences, number of mesh-related recurrences, number of non-mesh-related recurrences, number of unknown recurrences, patient comorbidities, and patient preoperative medical history. Mesh weight was considered to be the weight of the mesh following absorption of the composite component. A LW mesh is defined as a mesh weighing 35--50 g/cm^2^.[@CIT0012] A HW mesh is defined as any mesh above 50 g/cm^2^. Parameters with limited data were not analyzed.

Outcomes of interest {#S0002-S2004}
--------------------

The primary outcome was to describe recurrence rates in ventral PET and PP hernia repair. The secondary outcome was to describe infection rates in ventral PET and PP hernia repair.

Statistical analysis {#S0002-S2005}
--------------------

Primary and secondary outcomes were measured using incidence rate reported in individual groups from each single-arm study. Pooled estimation of risk was calculated using random effect model, as data come from literature review from heterogeneous and mainly non-randomized studies, using different methods and designs on various populations. An overlap between event rate confidence intervals from different groups suggests that there was no apparent trend in the results in favor of one group or the other. Sub-group analyses were performed on the basis of surgical approach (laparoscopic or open) and mesh weight (light or heavy). Summary of effect size and the associated forest plots were generated using Comprehensive Meta-Analysis software version 2.2 (Biostat, Inc.; Englewood, NJ, USA). All data are reported as pooled estimations of risk for hernia recurrence or infection. Results obtained on less than 5 studies are not reported.

Results {#S0003}
=======

One-hundred and nine articles were identified of which 81 articles satisfied all inclusion criteria. A total of 10,022 patients operated for ventral hernia repairs were included in the analysis. [Table S1](#ST0001) provides a descriptive summary of the included studies. Studies containing separate data on multiple subset populations are segregated in the appendix and treated as separate studies. In total, 81 studies resulted in 97 individual study data sets.

Analyses were performed to evaluate the pooled recurrence rate in ventral PET and PP hernia repair. Studies were separated based on mesh material (ie, PET or PP), approach (ie, open or laparoscopic), and mesh weight (ie, LW or HW). Due to insufficient papers and data, we were unable to report results on the following categories: recurrence rate in laparoscopic procedures using LW PET or PP meshes, recurrence rate using HW PP mesh, and seroma formation for both PET and PP mesh.

Recurrence rate {#S0003-S2001}
---------------

Overall recurrence rates are comparable between PET and PP with a recurrence rate of 4.8%, 95% CI \[3.5--6.5\] versus 4.7%, 95% CI \[3.7--6.0\] ([Figure 1](#F0001){ref-type="fig"}). Mesh weight did not have a significant impact on recurrence. Recurrence rates following hernia repair with LW PET mesh were 5.6%, 95% CI \[3.7--8.5\] compared to a 3.9%, 95% CI \[2.4--6.4\] rate with LW PP. ([Figure 2](#F0002){ref-type="fig"}). HW PET hernia repair recurrence rates were 4.0%, 95% CI \[2.6--6.2\] compared to 6.3%, 95% CI \[4.5--8.8\] with PP ([Figure 3](#F0003){ref-type="fig"}). Surgical approach did not have an impact on recurrence rate between laparoscopic and open repairs (3.3%, 95% CI \[2.2--5.0\] versus 5.2%, 95% CI \[4.29--6.4\] versus 4.9%, 95% CI \[3.9--5.7\], respectively). Recurrence rates among laparoscopic procedures were similar between PET and PP mesh (3.5%, 95% CI \[2.0--6.0\] and 3.0%, 95% CI \[1.6--5.7\]). Additional details are provided in [Table 1](#T0002){ref-type="table"}.Table 1PET and PP recurrence rate. Study arms with less than N=5 papers were excluded from subgroup analysisPETPPPET+PPRecurrence rateRecurrence rateOverall recurrence rateN% \[95% CI\]N% \[95% CI\]N% \[95% CI\]Ventral overall374.8 \[3.5--6.5\]724.7 \[3.7--6.0\]1094.7 \[3.9--5.7\]Laparoscopic143.5 \[2.0--6.0\]123.0 \[1.6--5.7\]263.3 \[2.2--5.0\]Open215.7 \[3.9--8.3\]594.9 \[3.9--5.7\]805.2 \[4.2--6.4\]Lightweight (LW)175.6 \[3.7--8.5\]183.9 \[2.4--6.4\]354.8 \[3.5--6.7\]Laparoscopic LW0--4--4--Open LW175.6 \[3.7--8.6\]144.6 \[2.6--7.8\]315.2 \[3.7--7.3\]Heavyweight (HW)204.0 \[2.6--6.2\]326.3 \[4.5--8.8\]525.3 \[4.1--7.0\]Laparoscopic HW143.5 \[2.0--6.1\]4--184.0 \[2.5--6.5\]Open HW4--276.0 \[4.1--8.6\]316.0 \[4.3--8.4\][^1] Figure 1Recurrence rate according to material.Figure 2Recurrence according to mesh weight.Figure 3Recurrence rate according to material and mesh weight.

Infection {#S0003-S2002}
---------

The aggregate infection rate for PET and PP mesh was similar (3.5%, 95% CI \[2.5--4.9\] vs 5.0%, 95% \[3.9--6.3\]). The infection rate for laparoscopic procedures (1.6%, 95% \[0.9--2.6\]) was markedly lower than open procedures (5.2%, 95% \[4.3--6.3\]) when using either mesh ([Figure 4](#F0004){ref-type="fig"}). Mesh weight did not appear to have an impact on infection rates (4.8% LW vs 4.6% HW). Additional details are provided in [Table 2](#T0003){ref-type="table"}.Table 2PET and PP infection rates. Subgroups with less than N=5 papers were excluded from analysisPETPPPET+PPInfection rateInfection rateOverall infection rateN% \[95% CI\]N% \[95% CI\]N% \[95% CI\]Ventral overall303.5 \[2.5--4.9\]605.0 \[3.9--6.3\]904.4 \[3.6--5.4\]Laparoscopic111.0 \[0.5--2.2\]102.2 \[1.1--4.4\]211.6 \[0.9--2.6\]Open184.8 \[3.3--6.7\]495.5 \[4.3--6.9\]675.2 \[4.3--6.3\]Lightweight (LW)144.9 \[3.2--7.5\]154.9 \[2.9--7.9\]294.8 \[3.4--6.7\]Laparoscopic LW0--2--2--Open LW145.1 \[3.5--7.2\]135.4 \[3.2--9.0\]275.1 \[3.6--7.1\]Heavyweight (HW)162.2 \[1.3--3.7\]266.5 \[4.7--9.0\]424.6 \[3.4--6.2\]Laparoscopic HW111.1 \[0.5--2.1\]4--151.3 \[0.7--2.6\]Open HW4--216.5 \[4.4--9.4\]256.0 \[4.3--8.4\][^2] Figure 4Infection rate according to the surgical technique.

Other complications {#S0003-S2003}
-------------------

Other complications, including hematoma and seroma, were not reported due to lack of data identified during the meta-analysis.

Discussion {#S0004}
==========

Mesh materials differ in manufacturing process, composition, density, weave, and pore size. Despite these variations, there is no significant difference in recurrence or infection rates in ventral hernia repairs using either multifilament PET or monofilament PP mesh. Previously reported complications and variations in outcomes were not identified when comparing larger numbers of patients. Furthermore, there were no differences in recurrence rates or infections rates identified between mesh materials or within a subgroup analysis evaluating LW and HW meshes independently. Despite some variability in published recurrence rates among published studies, with occasional outliers, the rate of hernia recurrence for LW PET and LW PP is similar.[@CIT0011] Patient selection, hernia characteristics, and patient comorbidities are likely to impact hernia repair outcomes beyond the influence of the mesh material alone and are likely to contribute to the variability in recurrence rates among studies. Nevertheless, mesh materials must have strength great enough to withstand physiologic intra-abdominal pressures, particularly when utilized as a bridge.[@CIT0006] The etiologies of primary mesh failure with central hernia recurrence include mesh degradation, trauma during implantation, or use in situations in which abdominal forces exceed mesh strength.

Hernia repair techniques are likely to impact hernia outcomes as well. Prior studies have demonstrated differences in hernia reoperation rates based upon mesh location with retro-rectus meshes demonstrating the lowest reoperation rates.[@CIT0013] Mesh location is equally important to mesh choice. This study was not able to evaluate the impact of mesh location on hernia repair outcomes due to the inability to clearly detect mesh location in the majority of patients.

Laparoscopic hernia repair has been previously shown to be associated with a reduced incidence of mesh infections with similar hernia recurrence rates to open hernia repair.[@CIT0014] Our overall infection rate using PET and PP mesh laparoscopically was 1%, 95% \[0.5--2.2\] and 2.2%, 95% \[1.1--4.4\], respectively, with overlapping confidence intervals. A comparative analysis of 79 laparoscopic PET mesh hernia repairs and 30 open extraperitoneal retrorectus PET mesh repairs reported infection rates less than 1% in laparoscopic cases and 13% for open procedures.[@CIT0015] Regardless of mesh type, laparoscopic repairs are associated with fewer mesh infections than open repairs, likely related to the avoidance of a laparotomy incision directly overlying the mesh.

The inherent limitations of this study are related to the quality and heterogeneity (in terms of design, follow-up, population, period, etc.) of the included studies. Studies including randomized controlled trial but also single-arm cohort studies with a minimum of 1-year follow-up were included to capture the incidence of both hernia recurrence and mesh infection. Prior studies have demonstrated that the majority of hernias occur within 2 years, and recurrence rates continue to increase beyond the 2-year postoperative interval.[@CIT0016] In the current analysis, inclusion of studies with follow-up duration of 1 year may underestimate the incidence of long-term recurrence. However, the similarity in recurrences seen in each of the mesh type would lead the authors to believe that long-term recurrence rates would also be similar. Publications including results in figure form without infection or recurrence rates stated within the text of the publication were not included within the analysis. Analyses for mesh brand, weight, or surgical approach were not performed due to insufficient number of studies. Various mesh brands are included in analyses, grouped by material type and mesh weight. Although similarity exists between mesh materials, the manufacturing processes for each product include unique weaves, pore size, and properties that may impact outcomes. Furthermore, this study was unable to evaluate the impact of mesh position location upon outcomes. Variability in reporting of mesh location in the included studies did not allow for us to evaluate the impact of mesh location upon hernia recurrences based upon mesh type. Accordingly, this study was unable to assess the impact of mesh location upon hernia mesh infection rates. The impact of factors such as undermining skin flaps or subcutaneous mesh placement, which has been associated with poor outcomes, could not be addressed.[@CIT0017] Additional known risk factors for hernia recurrence and complications including smoking status, history of COPD, diabetes, and BMI were unable to be addressed in this review due to inconsistent reporting. Finally, the literature review was quality controlled, and some manuscripts were excluded from using the same data. However, the analysis datasets may contain some patient data in duplicate though the authors believe this would only be in a very limited number of patients.

Conclusion {#S0005}
==========

Ventral hernia repairs can be safely performed using either monofilament PP or multifilament PET mesh with comparable rates of mesh infection and hernia recurrences. Each device has characteristics that require the identification of proper surgical technique (ie, laparoscopic versus open: retrorectus versus underlay or onlay) in an effort to balance the risk of infection and recurrence. Mesh selection should be tailored to each patient, subpopulation, and situation, with a continuation of head-to-head device trials to garner more long-term data.

Supplementary materials {#S0007}
=======================

Table S1Full list of study data setsFirst authorYearMaterialMesh weightSurgical approachNumber of patientsMean follow-up (months)Number of recurrencesNumber of mesh-related recurrencesNumber of infectionsAdloff M1987PETLIGHTOPEN13096667Ahmad M2003PPHEAVYOPEN2726001Alkhoury F2011PPHEAVYLAP141407--4Ammaturo C2004PETHEAVY--26151----Ammaturo C2010PETHEAVYOPEN10342614Armananzas L2014PPHEAVYLAP53122--0Arnaud J2003PETHEAVYLAP51121----Arroyo S A2002PP--OPEN213642--3Balique2005PETHEAVYOPEN51481114Bansal V2011PP--LAP3516.3000Basoglu2004PETLIGHTOPEN6152.86--6Becouarn1996PETLIGHTOPEN16036704Bensaadi H2014PPLIGHTOPEN41366--2Berrevoet F2010PP--OPEN205367--12Berrevoet F2011PPLIGHTOPEN5648.82--0Berrevoet F2009PPLIGHTLAP114274----Bessa S2013PPHEAVYOPEN8049.91----Bhanot P2013PPLIGHTLAP10050000Bingener J2004PPHEAVYLAP30141--0Bracci F2008PP--OPEN2624000Briennon2011PETHEAVYOPEN28012--1089012Champetier1978PETLIGHTOPEN512110--Champetier1990PETLIGHTOPEN54425--4Chelala E2010PETHEAVYLAP608522590Chowbey P2000PP--LAP20234.82--5Colon MJ2011PETHEAVYLAP50121--0Conze2005PETLIGHTOPEN34245--3de Ruiter P2005PP--OPEN46607--3del Pozo M2003PPHEAVYOPEN3223.6000Eriksen2011PETHEAVYLAP1916001Fei Y2012PPLIGHTOPEN2614.5001Gherardi2013PETHEAVYLAP11866400Ghnnam WM2009PPHEAVYOPEN2930002Gleysteen J2009PPHEAVYOPEN756615--9Gomez R2001PPHEAVYOPEN374266--Gronnier C2012PPHEAVYOPEN12124.617--12Gutierrez de la P C2003PPHEAVYOPEN5036001Guzman-Valdivia G2008PPLIGHTOPEN25122--2Guzman-Valdivia G2001PP--OPEN502400--Hadi H2006PPLIGHTOPEN51151--2Hamy2003PETLIGHTOPEN35097.2111114Han J2007PPHEAVYOPEN48322----Hasbahceci M2014PP--OPEN2542.61--0Iversen E2010PPLIGHTOPEN15215.64--4Janes A2004PPLIGHTOPEN27241--0Johanet2005PETHEAVYOPEN122123--2Korenkov M2002PPHEAVYOPEN39163--4Kulacoglu H2012PP--OPEN10012003Lahon2009PETHEAVYLAP71131301Lepère M2008PETHEAVYLAP29121----Lermite E2004PETHEAVYLAP2633001Lewis R1984PPHEAVYOPEN50303--2Liu F2011PPLIGHTOPEN3628004Luijendijk R2000PPHEAVYOPEN8426195--Machairas2004PETLIGHTOPEN4354.4433Mahmoud Uslu H2006PPHEAVYOPEN291556--8Maman D2012PP--OPEN404000--Martin-Duce A2001PPHEAVYOPEN284724--11Mathonnet1998PETLIGHTOPEN99124--6McCarthy JD1981PPHEAVYOPEN25482--1Mehrabi M2010PETLIGHTOPEN17696223Moreno-Egea2004PETHEAVYLAP8642330Moreno-Egea2004PETHEAVYLAP127645--1Moreno-Egea2008PETHEAVYLAP5518110Moreno-Egea2013PETHEAVYLAP512400--Moreno-Egea A2010PPLIGHTOPEN5048003Murtaza, B2009PP--OPEN3315.78001Nardi MJ2012PETHEAVYLAP87122--1Notash2007PETLIGHTOPEN5167.64----Novitsky Y2006PP--OPEN12828.1404Olmi S2006PETHEAVYLAP178294--1Paajanen H2004PPHEAVYOPEN84364----Petersen S2004PPHEAVYOPEN130205--6Piardi T2010PP--OPEN25751----Poelman, M2010PPHEAVY--1016416--22Poghosyan T2012PETLIGHTOPEN26258882Prasad P2011PP--LAP6822.72--0Qadri S2010PP--OPEN40261--6Quarmby C2001PPHEAVYOPEN3235.41--9Rives1985PETLIGHTOPEN218367018Rosen MR2014PETLIGHTOPEN361388--Rosen MJ2009PETHEAVY--109143--5Rosenberg J2008PPLIGHTLAP4917001Sauerland S2005PPHEAVYOPEN74604--2Schmidbauer S2005PPHEAVYOPEN69922--2Shukla V2005PP--OPEN5537002Steele S2003PP--OPEN5850.615--2Stoikes N2013PP--OPEN5019.5003Sugerman H1996PPHEAVYOPEN98204--17Trivellini G2001PP--OPEN27032.51--1van't R2002PPHEAVYLAP25164--1Veyrie N2013PETLIGHTOPEN61473--0Vijayasekar C2008PP--OPEN42314--1Vychnevskaia K2010PPLIGHTOPEN10128.52----Welty G2001PPHEAVYOPEN1152411----Wheeler2009PETLIGHTOPEN90466--10Yildirim M2010PPHEAVYOPEN2528003[^3]
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[^1]: **Abbreviations:** LW, Lightweight; HW, Heavyweight; PET, Polyester; PP, Polypropylene.

[^2]: **Abbreviations:** LW, Lightweight; HW, Heavyweight; PET, Polyester; PP, Polypropylene.
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